Abdul Rafae

Researcher

University of Arkansas for Medical Sciences

faculty

9 h-index 68 pubs 392 cited

Research Areas

Multiple Myeloma Research and Treatments Meta-analysis and systematic reviews Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Immune Response and Inflammation Cancer Immunotherapy and Biomarkers Cardiovascular Function and Risk Factors Health and Medical Research Impacts

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Abdul Rafae's research focuses on the efficacy and safety of various therapeutic regimens for hematological malignancies and other complex medical conditions. His work includes systematic reviews and meta-analyses of randomized controlled trials, examining treatments for relapsed and refractory multiple myeloma, newly diagnosed multiple myeloma, and multicentric Castleman disease. Rafae has also investigated the role of specific agents such as belantamab mafodotin and venetoclax in multiple myeloma treatment, as well as the impact of immunotherapy versus chemotherapy in advanced non-small cell lung cancer. Additional research areas include the management of ocular toxicity associated with oncological therapies and the comparison of blood transfusion strategies in patients with acute myocardial infarction. His scholarship metrics include an h-index of 9, with 68 total publications and 392 total citations.

Metrics

h-index: 9
Publications: 68
Citations: 392

Selected Publications

A Systematic Review on Efficacy and Safety Profile of Blinatumomab in Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R BCP-ALL) in Children and Young Adults (2024) DOI
Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients; A Scoping Review (2023) DOI